IceCure Medical Ltd. (ICCM) Form 6-K — Nov 2, 2026
IceCure Medical has called a Special General Meeting for November 19, 2026, with a single proposal: authorize one or more reverse share splits at board discretion, each at a minimum of 5-for-1 and cumulatively capped at 40-for-1, exercisable within 24 months. The stated purpose is to maintain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum $1.00 bid price — an explicit signal the stock is at risk of falling below listing thresholds. The board unanimously recommends voting FOR, and the broad discretionary ratio range means management could execute multiple splits without further shareholder approval.
Key figures
- Record date
- November 4, 2026
- Meeting date
- November 19, 2026
- Authorized shares
- 2500000000
- Reverse split ratio
- 5-for-1 to 40-for-1 cumulative (board discretion)
- Quorum threshold percent
- 25
- Authorization window months
- 24
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.